Krystal Biotech (KRYS) PT Lowered to $73 at Goldman Sachs, Following Earnings

May 10, 2021 3:36 PM EDT Send to a Friend

Goldman Sachs analyst Madhu Kumar ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Krystal Biotech (KRYS) PT Lowered to $73 at Goldman Sachs, Following Earnings

Member Login

Free News Feed